Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy.
Niu X, Wu M, Li G, Zhou X, Cao W, Zhai W, Wu A, Zhou X, Jin S, Chen G, Li Y, Du J, Wu Y, Qiu L, Zhao W, Gao Y.
Niu X, et al. Among authors: zhai w.
Acta Pharm Sin B. 2023 Nov;13(11):4511-4522. doi: 10.1016/j.apsb.2023.08.003. Epub 2023 Aug 9.
Acta Pharm Sin B. 2023.
PMID: 37969728
Free PMC article.